Ian Scholes
Follow
Get notifications in MyBN when activity occurs.
Ian Scholes
Non-Executive Director, Deputy Chair since 2021 / Mayne Pharma Group
Ian Scholes has financial and corporate advisory experience in Australia and internationally.
Mr Scholes is a partner and chief executive of Chord Capital.
Mr Scholes was vice chair of investments banking at Merrill Lynch Australia and executive general manager at National Australia Bank, running the corporate and institutional banking division. He was also chair of the St Vincent's Foundation and former director of SDI.
Mr Scholes is a partner and chief executive of Chord Capital.
Mr Scholes was vice chair of investments banking at Merrill Lynch Australia and executive general manager at National Australia Bank, running the corporate and institutional banking division. He was also chair of the St Vincent's Foundation and former director of SDI.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 82nd | Mayne Pharma Group | 105% | -13% |
| 357th | PWR Holdings | 24% | 29% |
| 594th | Regal Investment Fund | 5% | |
| 1001st | Retail Food Group | -19% | -23% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 348th |  | Mayne Pharma Group | $193.0m |
| 413th |  | PTB Group | $125.2m |
| 414th | | Regal Investment Fund | $124.8m |
| 417th | | Retail Food Group | $120.7m |
| 418th | | PWR Holdings | $120.2m |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| REMUNERATION UPDATE: Non-Executive Director, Deputy Chair since 2021, Mayne Pharma Group | 13 Nov 2020 |
| NEW ROLE: Non-Executive Director, Deputy Chair since 2021, Mayne Pharma Group | 03 Nov 2020 |
